EMS Pharma Surpasses Pharma Giants in Generics War
According to a new research report by RNCOS entitled, "Brazil Pharmaceutical Market Outlook 2018", the Pharmaceutical industry of Brazil is a conglomerate market of domestic and international companies. As long as leading pharmaceutical players have been grappled with expiring patents and pricing pressures in developed markets, they are starting to expect more from emerging markets like Brazil. As in Brazil, the Ministry of Health is encouraging local manufacturers with reduced drug prices policies, increasing research and development; and boosting generics...
View full press release